# Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD)

> **NCT04842955** · NA · COMPLETED · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 60 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** Gamma tACS (40 Hz) over the superior parietal cortex
- **DEVICE:** Sham tACS over the superior parietal cortex

## Key facts

- **NCT ID:** NCT04842955
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842955, "Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04842955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*